AMX0035 PDUFA date

The PDUFA goal date for AMX0035 (Proprietary formulation of taurursodiol and sodium phenylbutyrate) in treatment of ALS was in Sep 2022, as disclosed by Amylyx Pharmaceuticals Inc. (AMLX).

PDUFA date
Sep 2022
Condition
treatment of ALS

Drug identity checked against registry records

Also recorded as Proprietary formulation of taurursodiol and sodium phenylbutyrate; RELYVRIO; Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO, also known as Ursodoxicoltaurine or Tauroursodeoxycholic Acid [TUDCA]); Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO; also known as Tauroursodeoxycholic Acid [TUDCA])

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's DiseaseNCT03533257AMLXPhase 2Completed2020-10-22Actual
AMX0035 and Progressive Supranuclear PalsyNCT06122662AMLXPhase 2, Phase 3Completed2025-09-30Actual
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis TreatmentNCT05021536AMLXPhase 3Unknown2024-01-19Actual
AMX0035 in Adult Patients With Wolfram SyndromeNCT05676034AMLXPhase 2Active not recruiting2024-07-23Actual
AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)NCT03127514AMLXPhase 2Completed2019-09-25Actual
Open Label Extension Study of AMX0035 in Patients With ALSNCT03488524AMLXPhase 2Completed2021-03-01Actual
Extension Study Evaluating The Safety And Tolerability of AMX0035NCT05619783AMLXPhase 3Completed2024-10-16Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-09MonthAMX0035Amylyx Pharmaceuticals Inc. · AMLXCompany-disclosed PDUFA goal dateAnnounced review targettreatment of ALSOpen original source
Read source excerpt

the FDA originally set the PDUFA date for AMX0035 for the treatment of ALS, for June 29, 2022, and then extended the review timeline for our NDA to September 2022

First seen: 08 Nov 2026 · Evidence last checked: 08 Nov 2026